BNKS
🇦🇺 ASX
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💰
2.25%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
15
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
BNKS.AX was created on 2016-07-28 by BetaShares. The fund's investment portfolio concentrates primarily on financials equity. BNKS.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global banks (ex-Australia), hedged into Australian dollars.
📈 Performance
Price History
+16.10%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
5.23%
4.86%
4.12%
3.38%
2.70%
Updated as of 13 May 2023
Industry Exposure
📙 Other
34%
📞 Communication
33%
🏦 Financials
31%
🤖 Information
2%
Country Exposure
Other
77%
🇺🇸 United States of America (the)
12%
🇨🇦 Canada
5%
🇸🇬 Singapore
4%
🇬🇧 United Kingdom of Great Britain and Northern Ireland (the)
3%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
2.25%
💰 Annual Distribution Earnings Per $1,000 invested**
$22.48
💰 Most Recent Distribution Franked Percentage Estimate
0.00%
💰 Average Distribution Franked Percentage Estimate
0.00 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.07
NaN%
2021
$0.25
0.00%
2020
$0.12
NaN%
2019
$0.09
NaN%
2018
$0.27
0.00%
2017
$0.11
0.00%
2016
$0.00
0.00%
2015
$0.00
0.00%
💵 Costs
💼
0.57%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$5.84
💰 Price To Earnings Ratio
8.02
💰 Price To Book Ratio
0.80
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in BNKS
15
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in BNKS
528 days
BNKS investor breakdown
💵 Income of investors
More than 200k
6%
150k - 200k
19%
100k - 150k
13%
50k - 100k
31%
Less than 50k
31%
👶 Age of investors
18 - 25
26 - 34
27%
35 - 90
67%
🙋 Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in BNKS also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
📊 Share price
$100.01 AUD
NULL GLOBAL
NULL OTHER
NULL SMART BETA
NULL THEMATIC
NULL INDEX
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
📊 Share price
$120.79 AUD
NULL AUSTRALIA
NULL BETA
Want more shares? Try these...
Blue Star Helium Ltd. engages in the exploration and development of oil and gas properties. The company is headquartered in Subiaco, Western Australia. The firm is engaged in finding and developing new supplies of high-grade helium in North America. The company has an on-going helium prospect generation program focusing on Utah, Colorado, Arizona and New Mexico. The total land position of the Company and its subsidiaries in Las Animas County, Colorado totaled approximately 306,581 gross (224,316 net) acres. The firm has contiguous leasing prospects, including Serenity, Enterprise, Pegasus, Galactica and Voyager.
📊 Share price
$0.03 AUD
Bionomics Ltd. is a clinical stage biopharmaceutical company. The firm is focused on developing allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with unmet medical needs. The firm operates in the drug development segment in Australia. The firm is advancing its lead drug candidate, BNC210, which is an oral, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). Its α7 Receptor Positive Allosteric Modulators (PAMs) pipeline is targeting cognitive dysfunction associated with Alzheimer’s disease and other central nervous system conditions. The company also includes a pre-clinical CNS pipeline that has two earlier-stage small molecule discovery programs targeting ion channels and representing opportunities for clinical programs.
📊 Share price
$0.02 AUD
Beamtree Holdings Ltd. is an Australian healthcare technology company. The company is headquartered in Sydney, New South Wales and currently employs 45 full-time employees. The company went IPO on 2019-06-06. The principal activity of the Company includes provision of software services to the healthcare industry. The firm has a range of licensing, data analytics products, coding, and benchmarking services to assist healthcare providers across different regions. Its products and services include PICQ, RippleDown Expert, RippleDown Auditor, Risq, Q Coding Platform and CodeXpert. RippleDown Expert automatically applies clinical solutions to generate patient-centric reports. RippleDown Auditor automates real-time reviews of all data, ensuring accuracy across data entry, billing, and specimen processing, flagging suspected errors as they arise. Its Q Coding platform provides an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing. Its CodeXpert installable Windows application, providing fully searchable classification reference information for the clinical coding of patient records.
📊 Share price
$0.28 AUD
BNDS.AX was created on 2018-11-07 by BetaShares. The fund's investment portfolio concentrates primarily on broad credit fixed income. The Fund aims to earn an after fee return in excess of the Bloomberg AusBond Composite 0+yr Index over rolling three year periods.
📊 Share price